Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 17.9.2024Zentiva, k.s. (ZNT-1)7819BPERSEN forte (cps dur 40(4x10)x87,5 mg/17,5 mg/17,5 mg (blis.PVC/PCTFE/Al))17.9.2024R
 17.9.2024Teva B.V. (TEV-NL-4)4270ETeriflunomid Teva 14 mg filmom obalené tablety (tbl flm 28x1x14 mg (blis. OPA/Al/PVC/Al) - jednotk.bal.))20.9.2024Z
 17.9.2024Novo Nordisk A/S (NOO)2772CFiasp 100 jednotiek/ml injekčný roztok naplnený v injekčnom pere (sol inj 10(2x5)x3 ml/300 U (pero napl.-skup.bal.))8.4.2024O
 16.9.2024BIOMEDICA spol. s r.o. (BCS)25553KALIUM CHLORATUM BIOMEDICA (tbl ent 100x500 mg (blis.PVC/Al))12.9.2024R
 16.9.2024Sandoz Pharmaceuticals d.d. (SAN-SLO-1)2780BQuetiapin Sandoz 300 mg (tbl plg 60x300 mg (blis.PVC/PCTFE/Al))1.9.2024R
 16.9.2024Sandoz Pharmaceuticals d.d. (SAN-SLO-1)28856Amoksiklav 2x1000 mg (tbl flm 14x1000 mg (blis.Al/Al))12.9.2024R
 16.9.2024Sandoz Pharmaceuticals d.d. (SAN-SLO-1)2135DDipperam HCT 10 mg/160 mg/25 mg filmom obalené tablety (tbl flm 28x10 mg/160 mg/25 mg (blis.PVC/PVDC/Al))12.9.2024R
 16.9.2024Sandoz Pharmaceuticals d.d. (SAN-SLO-1)9194BAmlodipín/Valsartan Sandoz 5 mg/160 mg (tbl flm 28x5 mg/160 mg (blis.PVC/PVDC))1.9.2024R
 16.9.2024Sandoz Pharmaceuticals d.d. (SAN-SLO-1)2422AContiroxil 40 mg tablety s predĺženým uvoľňovaním (tbl plg 56x40 mg (blisPVC/PE/PVDC))12.9.2024R
 16.9.2024Sandoz Pharmaceuticals d.d. (SAN-SLO-1)9181BAmlodipín/Valsartan Sandoz 5 mg/80 mg (tbl flm 28x5 mg/80 mg (blis.PVC/PVDC))1.9.2024R
 16.9.2024Sandoz Pharmaceuticals d.d. (SAN-SLO-1)99949Ciprofloxacín Sandoz 500 mg filmom obalené tablety (tbl flm 20x500 mg (blis.PP/Al))1.9.2024R
 16.9.2024Sandoz Pharmaceuticals d.d. (SAN-SLO-1)58702TAMOXIFEN Sandoz 20 mg (tbl 100x20 mg (liek.PP))12.9.2024R
 16.9.2024Sandoz Pharmaceuticals d.d. (SAN-SLO-1)52466Fludarabin Sandoz 25 mg/ ml injekčný alebo infúzny koncentrát (con ijf 1x2 ml/50 mg (liek.inj.skl.))1.9.2024R
 16.9.2024Sandoz Pharmaceuticals d.d. (SAN-SLO-1)2163DDipperam HCT 10 mg/160 mg/12,5 mg filmom obalené tablety (tbl flm 28x10 mg/160 mg/12,5 mg (blis.PVC/PVDC/Al))1.9.2024R
 16.9.2024B.Braun Melsungen AG (BME)34254Glukóza B. Braun 5 % infúzny roztok (sol inf 10x500 ml (fľ.LDPE))25.9.2024R

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)